APA
Chughlay M. F., Rossignol E., Donini C., El Gaaloul M., Lorch U., Coates S., Langdon G., Hammond T., Möhrle J. & Chalon S. (20210728). First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. : British journal of clinical pharmacology.
Chicago
Chughlay M Farouk, Rossignol Emilie, Donini Cristina, El Gaaloul Myriam, Lorch Ulrike, Coates Simon, Langdon Grant, Hammond Tim, Möhrle Jörg and Chalon Stephan. 20210728. First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. : British journal of clinical pharmacology.
Harvard
Chughlay M. F., Rossignol E., Donini C., El Gaaloul M., Lorch U., Coates S., Langdon G., Hammond T., Möhrle J. and Chalon S. (20210728). First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. : British journal of clinical pharmacology.
MLA
Chughlay M Farouk, Rossignol Emilie, Donini Cristina, El Gaaloul Myriam, Lorch Ulrike, Coates Simon, Langdon Grant, Hammond Tim, Möhrle Jörg and Chalon Stephan. First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection. : British journal of clinical pharmacology. 20210728.